Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-22

Clinical Trial Update: Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating early, systematic thyroid hormone replacement after radioactive iodine ablation in Graves' disease and its impact on quality of life,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Graves Disease (Basedow's Disease) | Phase 3 | Status: COMPLETED